PetVivo Holdings, Inc. (PETVW) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Minneapolis, MN, 미국. 현재 CEO는 John Lai.
PETVW 을(를) 보유 IPO 날짜 2021-08-11, 20 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $732.06K.
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
